MedPath

Hydrocortisone

Generic Name
Hydrocortisone
Brand Names
Ala-cort, Ala-scalp, Alcortin, Alkindi, Anusol HC, Aquanil HC, Casporyn HC, Cipro, Cipro HC, Colocort, Cortaid, Cortane-B, Cortef, Cortenema, Cortisporin, Cortizone-10, Dermacort, Dermarest Eczema, Dermazene, Home Papkit, Hydroskin, Monistat Itch Relief, Neosporin Eczema, Preparation H Hydrocortisone, Procto-med, Procto-pak, Proctocort, Proctol, Proctosedyl, Proctosol, Proctozone HC, Scalpicin Itch Relief, Texacort, Vanoxide-HC, Xerese, Plenadren, Efmody
Drug Type
Small Molecule
Chemical Formula
C21H30O5
CAS Number
50-23-7
Unique Ingredient Identifier
WI4X0X7BPJ

Overview

Hydrocortisone, or cortisol, is a glucocorticoid secreted by the adrenal cortex. Hydrocortisone is used to treat immune, inflammatory, and neoplastic conditions. It was discovered in the 1930s by Edward Kendall and named Compound F, or 17-hydroxycorticosterone. Hydrocortisone was granted FDA approval on 5 August 1952.

Indication

Otic solutions are indicated for infections of the external auditory canal caused by susceptible organisms and with inflammation. Hydrocortisone tablets are indicated for certain endocrine, rheumatic, collagen, allergic, ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, and other conditions. A hydrocortisone enema is indicated for ulcerative colitis, a topical ointment with antibiotics is indicated for corticosteroid responsive dermatoses with infections, and a topical cream with acyclovir is indicated to treat cold sores. Oral granules of hydrocortisone are used as a replacement therapy for Adrenocortical Insufficiency (AI) in children under 17 years of age.

Associated Conditions

  • Acute Gouty Arthritis
  • Acute Leukemia
  • Acute Otitis Externa
  • Adrenal Insufficiency
  • Allergic Conjunctivitis (AC)
  • Allergic Rhinitis (AR)
  • Allergic corneal marginal ulcers
  • Ankylosing Spondylitis (AS)
  • Aspiration Pneumonitis
  • Asthma
  • Atopic Dermatitis
  • Berylliosis
  • Bullous dermatitis herpetiformis
  • Chorioretinitis
  • Choroiditis
  • Congenital Adrenal Hyperplasia (CAH)
  • Congenital Hypoplastic Anemia
  • Contact Dermatitis
  • Crohn's Disease (CD)
  • Dermatitis
  • Dermatomyositis (DM)
  • Dermatosis
  • Drug hypersensitivity reaction
  • Epicondylitis
  • Erythroblastopenia
  • Fissure;Anal
  • Haemorrhoids
  • Herpes Labialis
  • Hypercalcemia of Malignancy
  • Immune Thrombocytopenia (ITP)
  • Infection of the Fenestration Cavity
  • Infection of the Mastoidectomy Cavity
  • Iridocyclitis
  • Iritis
  • Itching caused by Hemorrhoids
  • Itching of the Anus
  • Keratitis
  • Leukemias
  • Loeffler's syndrome
  • Lymphoma
  • Lymphomas NEC
  • Mycosis Fungoides (MF)
  • Ophthalmia, Sympathetic
  • Optic Neuritis
  • Pain caused by Hemorrhoids
  • Pemphigus
  • Posterior Uveitis
  • Posttraumatic Osteoarthritis
  • Primary adrenocortical insufficiency
  • Proctitis
  • Proteinuria
  • Pruritis of the skin
  • Psoriatic Arthritis
  • Rectal inflammations NEC
  • Rheumatic heart disease, unspecified
  • Rheumatoid Arthritis
  • Rheumatoid Arthritis, Juvenile
  • Secondary adrenocortical insufficiency
  • Secondary thrombocytopenia
  • Serum Sickness
  • Severe Seborrheic Dermatitis
  • Skin Diseases
  • Stevens-Johnson Syndrome
  • Synovitis
  • Systemic Lupus Erythematosus
  • Trichinosis
  • Tuberculous Meningitis
  • Ulcerative Colitis
  • Acquired immune hemolytic anemia
  • Acute Bursitis
  • Acute Tenosynovitis
  • Acute rheumatic carditis
  • Anterior eye segment inflammation
  • Cryptitis
  • Disseminated Pulmonary Tuberculosis (TB)
  • Exfoliative erythroderma
  • Fulminating Pulmonary Tuberculosis
  • Non-suppurative Thyroiditis
  • Severe Erythema multiforme
  • Severe Psoriasis
  • Subacute Bursitis
  • Superficial infection of the external auditory canal with inflammation
  • Symptomatic Sarcoidosis
  • Systemic Dermatomyositis
  • Varicella-zoster virus acute retinal necrosis

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/07/18
Not Applicable
Not yet recruiting
2025/05/21
Phase 4
Recruiting
Walter Reed Army Institute of Research (WRAIR)
2025/04/24
Early Phase 1
Not yet recruiting
C17 Council
2025/04/16
Not Applicable
ENROLLING_BY_INVITATION
Nada kamel Elgamal
2025/03/26
Phase 2
Not yet recruiting
2025/03/25
Phase 4
Not yet recruiting
Copenhagen Respiratory Research
2025/03/25
Phase 4
Not yet recruiting
Copenhagen Respiratory Research
2024/12/09
Not Applicable
Recruiting
Southeast University, China
2024/07/23
N/A
Active, not recruiting
2024/07/16
Phase 1
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
MWI
13985-608
OPHTHALMIC
10 mg in 1 g
3/23/2015
Westminster Pharmaceuticals, LLC
69367-286
TOPICAL
10 mg in 1 g
5/12/2023
NuCare Pharmaceuticals,Inc.
68071-1598
TOPICAL
25 mg in 1 g
4/19/2023
Actavis Pharma, Inc.
0472-0321
TOPICAL
10 mg in 1 g
6/30/2017
Unipack LLC
43749-620
TOPICAL
10.2 mg in 1 g
7/13/2025
Chattem, Inc.
41167-0039
TOPICAL
10 mg in 1 g
4/10/2025
Eton Pharmaceuticals, Inc.
71863-112
ORAL
5 mg in 1 1
2/28/2024
Akorn Operating Company LLC
50383-901
AURICULAR (OTIC)
10.375 mg in 1 mL
10/13/2022
Bryant Ranch Prepack
63629-2396
TOPICAL
25 mg in 1 g
2/15/2022
NuCare Pharmaceuticals,Inc.
68071-4229
AURICULAR (OTIC)
10 mg in 1 mL
6/16/2023

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
Neurocrine Netherlands B.V.,Van Heuven Goedhartlaan 935 A,1181 LD Amstelveen,NETHERLANDS
Authorised
5/27/2021
Neurocrine Netherlands B.V.,Van Heuven Goedhartlaan 935 A,1181 LD Amstelveen,NETHERLANDS
Authorised
2/9/2018
Authorised
11/3/2011

HSA Drug Approvals

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Hydrocortisone Tablets
国药准字H31020777
化学药品
片剂
7/8/2020
Hydrocortisone Tablets
国药准字H61021659
化学药品
片剂
11/11/2020
Hydrocortisone Tablets
国药准字H37020302
化学药品
片剂
3/11/2020
Hydrocortisone Tablets
国药准字H23021654
化学药品
片剂
12/7/2020
Hydrocortisone Tablets
国药准字H53021390
化学药品
片剂
9/28/2020
Hydrocortisone Tablets
国药准字H41020790
化学药品
片剂
5/18/2020
Hydrocortisone Tablets
国药准字H20058186
化学药品
片剂
8/4/2020
Hydrocortisone Tablets
国药准字H41020599
化学药品
片剂
7/16/2020
Hydrocortisone Tablets
国药准字H15020177
化学药品
片剂
3/29/2020
Hydrocortisone Tablets
国药准字H23021781
化学药品
片剂
7/26/2023

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.